• Immunology
• Immune System
• Cancer Immunology and Immunotherapy
• Immunotoxicology
• Neuroimmunology
• Immunodeficiency
• Epidemiology
• Transplantation Immunology
• Immunotherapy
• Immunoinformatics & Systems immunology
• Immunological techniques
• Immunogenetics
• Pediatrics Immunology
• Diagnostic and Technological novelty of Immunology
• Viral Immunology
• Parasite Immunology
• Reproductive Immunology
• Cellular and molecular immunology
• Stem cells immunology

 The global immunology market size was valued at USD 77,365.4 Million in 2018 and is projected to reach USD 143,833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period.

Existing market players operating in the global immunology market are focusing on constant innovations and up-gradation of their product portfolio with new and efficient product offerings for better treatment outcomes for the patients. One of the primary reasons for the growth of the global market is the increasing incidence of immunological and autoimmune diseases. Rise in awareness regarding immunological diseases in both developing and developed nations, and the higher prevalence of immunological disorders due to environmental factors, thus propelling the of the global immunology market growth. This coupled with, increasing investments by major players in research and development activities are also boosting the growth of the market globally.

The change in the immunology market share is also primarily driven by a greater focus towards the R&D initiatives due to recent regulatory approvals, increasing trends of patent expiry and the subsequent emergence of comparatively cheaper biosimilars. Some of the other factors which are also contributing to the growth of the market are the increase in the efficiency of the immunology drugs leading to better patient outcomes and improved quality of life.

The introduction of new and sophisticated targeted therapies such as TREMFYA by Janssen Global Services, LLC (Johnson & Johnson) and Cosentyx by Novartis AG is expected to drive the growth of the immunology market in developed as well as emerging countries, during the forecast period 2019-2026.

"Increasing adoption of monoclonal antibody (mAb), combined with the increasing prevalence of immunological diseases is driving the growth of the global market"

Increasing adoption and demand for monoclonal antibody (mAb), which is the drug class of a number of immunology drugs and has a number of associated advantages such as its status as a high specific therapy, is one of the most prominent driving factors for the growth of the global immunology industry in 2018. Increasing R&D initiatives in the monoclonal antibody segment and a large number of drugs under the segment is also driving the growth in the monoclonal antibody (mAb) segment.

The immunosuppressant segment is estimated to grow at a faster CAGR during the forecast period. This is attributed to the anticipated increase in the revenue under this drug class, with the interleukin inhibitors becoming more prominent in the immunology market trend. Currently, there is increasing adoption of the immunosuppressants in the markets in the developing nations due to its higher achievement in terms of the efficient treatment leading to improved patient outcomes, and this is expected to contribute to the growth of the market at higher CAGRs during the forecast period.

Regional Analysis

"Growing Prevalence and Awareness of Autoimmune and Immunological Disorders and Increasing Adoption of Immunology Drugs Expected to Result in the Highest CAGR in the Asia Pacific"

North America generated revenue of US$ 41,622.5 Mn in 2018 and is anticipated to account for a dominant share in the global market during the forecast period. The immunology market growth witnessed in the region is likely to be driven by the increasing adoption of advanced immunology drugs and rising prevalence of autoimmune and immunological disorders.

This is especially applicable in instances where there is a steady escalation of the symptoms and the disease progresses due to lack of efficient treatment. In developed countries, the adoption of advanced immunology drugs such as immunosuppressants is increasing along with the existing drug classes of monoclonal antibody (mAb) and polyclonal antibody (pAb) amongst others

Euro Immunology 2018

Euro Immunology 2018 Report

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, and Associations for making Euro Immunology 2018 Conference the best ever!

The “9th European Immunology Conference Associated with Antibody Engineering Meeting” , hosted by the Conferenceseries LLC Ltd was held during June 14-16, 2018 Amsterdam, Netherlands based on the theme “Disseminating the New Trends in Immunology". Benevolent response and active participation was received from the Organizing Committee Members along with Professors, Researchers, Students and leaders from various fields of Immunology and Vaccine Development, who made this event a grand success.

Conferenceseries LLC Ltd expresses its gratitude to the conference Moderator, for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

• Thomas Böldicke, Helmholtz Centre for Infection Research, Germany               
• Andreas Weinhaeusel, Austrian Institute of Technology GmbH, Austria
• Erik Wambre, Benaroya Research Institute, USA
• Loredana Frasca, Istituto Superiore di Sanità, Italy
• Ena Ray Banerjee, University of Calcutta, India
• Fa-Ping Wang, Sichuan University, China
• Tjie Kok, University of Groningen, Netherlands
• Wen Qiu, Nanjing Medical University, China
• Luca Fania, Istituto Dermopatico dell’Immacolata-IRCCS, Italy
• Yong-Sung Kim , Ajou University, South Korea 

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

• Allergy and Therapies
• Innate Immune Responses
• Cellular Immunology
• Infectious Diseases

and Immune System

• Antibody Engineering
• Cancer Immunology
• Clinical Immunology
• Innate Immunity
• Transplantation Immunology
• Immunotherapy
• Immunoinformatics & Systems immunology
• Viral Immunology
• Cellular and molecular immunology

Euro Immunology 2018 Conference offers its heartfelt appreciation to Organizing Committee Members, Honourable Guests, Chair, various outside experts, company representatives, eminent personalities who interlaced with Conference and supported the conference in every aspect, without your support the conference would not be possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Immunology2020.

Euro Immunology 2018 Conference would like to announce the commencement of the “Immunology2020” to be held during October 26-27, 2020. Amsterdam, Netherlands we welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Immunology and cell Biology.

For More details: https://immunology.conferenceseries.com/

Let us meet again @ Immunology 2020